ACXP
Acurx Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.14
+3.64%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-92.1%
Return on equity
-68.3%
Return on assets
-94.1%
Return on invested capital
0.00x
Asset turnover
-$6.2M
Cash from operations
$1.95
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026